HOME >> BIOLOGY >> NEWS
CRESIB coordinates an international consortium to fight malaria caused by Plasmodium vivax

The CRESIB has today presented the research programme on malaria by Plasmodium vivax, a parasite causing over 70 million yearly cases of malaria in the world. This new programme will be developed in coordination with the leading international centres and researchers on P.vivax. The aim of this study is to contribute to a better understanding of malaria by P. vivax and to support and accelerate the development of new control tools, with a special focus in vaccines. This fact will promote the creation and development of a research line on P. vivax in CRESIB under the direction of Dr. Hernando A. del Portillo, one of the few specialists in molecular biology and vaccine development against this parasite. The number of CRESIB labs will be increased, with an enlargement and restoration of current facilities to meet the needs of the centre.

Malaria is an infectious disease which can be caused by four species of the Plasmodium parasite: P. falciparum, P. vivax, P. malariae and P. ovale. P. falciparum and P. vivax are the most prevalent, the first being more virulent and responsible of most of the severe morbidity and mortality. Nevertheless, during the last years, there has been a growing interest in malaria by P. vivax, which, as well as causing millions of malaria cases every year, it also generates a high social and economic cost for endemic countries. It is estimated that about 2,600 million people live in risk zones for P. vivax: central and south-America, Asia, Middle East and occidental Pacific. Clinical and pathogen presentation of P. vivax is not well understood. Despite the traditional belief that clinical malaria caused by this species of the parasite is mild, there are evidences suggesting that it can cause severe clinical patterns and even death of patients.

The paradox is that even though malaria by P. vivax has large global disease burden, this is a poorly studied disease,
'"/>

Contact: Marc de Semir
mdesemir@clinic.ub.es
34-932-275-700
IDIBAPS - Institut d'Investigacions Biomdiques August Pi i Sunyer
17-Jul-2007


Page: 1 2

Related biology news :

1. NYU biologists identify gene that coordinates two cellular processes
2. American buffalo slaughter fueled by international trade
3. 2 MSU professors spearhead international water project
4. Nature surrenders flowery secrets to international team
5. Fibers are center stage at international conference
6. Creation of an international industrial chair in life cycle assessment
7. The Institute of Ecosystem Studies to host an international conference on ecology and urban design
8. No sign that ethnic groups genes cause diabetes, international research team says
9. Research director to be honored at international congress
10. First international conference on self-healing materials
11. Case Western researcher, international team call for better global warming forecasting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/5/2019)... ... July 05, 2019 , ... SteriTrack Inc. is pleased ... to governments around the world. , Powered by Microsoft Azure, the Tractus™ ... solutions to operating theatres worldwide to address new global regulations mandating all medical ...
(Date:6/24/2019)... (PRWEB) , ... June 24, 2019 , ... According to ... with one of the four most common STDs: chlamydia, gonorrhea, trichomoniasis (or "trich") and ... reported that gay and bisexual African American men accounted for the largest number of ...
(Date:6/18/2019)... ... June 18, 2019 , ... Cirrascale ... introduced Data Science Workstations-as-a-Service as part of its dedicated, multi-GPU, deep learning cloud ... Data Science Workstations feature NVIDIA® Quadro RTX™ GPUs for up to 260 teraflops ...
Breaking Biology News(10 mins):
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ... device industries, announced today that they will be receiving 3 awards at the 2019 ... WCCT received 2 awards in the categories of overall Quality and Compatibility (Access to ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... interest to our methodology, processes, and diagnostic techniques. The patent applications titled ... IP rights including our proprietary sleep scoring methodology. The approval and success ...
(Date:5/31/2019)... (PRWEB) , ... May 30, 2019 , ... ... neurotoxins, is pleased to announce the strategic acquisition of Metabiologics, Inc., a globally ... acquisition provides Object exclusive ownership and commercialization rights to a full spectrum of ...
(Date:5/22/2019)... ... May 22, 2019 , ... Artemis (formerly Agrilyst), the leading ... A funding round co-led by Astanor Ventures and Talis Capital ... and iSelect Fund . The company has raised $11.75m to date and will ...
Breaking Biology Technology:
Cached News: